Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that in the National Institutes of Health (NIH) sponsored, Diabetic Retinopathy Clinical Research Network ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE